. Phosphatase (CIP) treatment of CH12F3 cell extracts analyzed by western blot; no effect on UNG1 band migration. Whole cell extract were generated as described in the method section, except that phosphatase inhibitor cocktails were excluded. Extracts (100 µg total protein) were treated with CIP (10 U) in10 µl reactions at different time points and temperatures as indicated. Samples representing 50 µg protein were analyzed by western blot analysis using antibody against mouse UNG as described. An unspecific band (~60kD) on the same western blot indicated active CIP treatment but CIP did not change the migration pattern on the UNG1 protein bands. Western blot comparing equal amounts (7 µg total protein) of WCE and mitochondria-enriched extract (MEE) derived from CH12F3 WT cells. The mitochondrial protein MRLP11 was used as mitochondrial marker and RPA2 was used as a nuclear marker. C. Mitochondria were isolated from CH12F3 UNG2-KO cells. Half of the mitochondria were treated with 60 µg/ml Proteinase K (PK) at 20°C for 30 min before preparation of mitochondrial extracts. Extracts generated from equal amounts of untreated and PK-treated mitochondria and the cytosol (Cyt) fractions were loaded on the gel. UNG1-HMW is degraded while the UNG1-LMW variant is more resistant to the PK treatment (marked with *). D. Western blot of transfected NIH-3T3 cells comparing GFP and mUNG1-1-38-GFP in mitochondrial (MEE), nuclear (NuE), and cytosolic fractions. Note that the processed form of mUNG1-1-38 dominates in MEE but is not detected in the NuE fraction E. Western blot showing UNG1-1-38-GFP in WCE compared to MEE. F. The processed form of mUNG1-1-38-GFP is resistant to PK treatment. Mitochondria were treated with increasing amounts of PK as indicated at 37°C for 30 min.
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Supplementary Figure S3 Figure S4 . Identification of the proteolytic cleavage sites in mouse UNG1 N-terminal region by targeted MS. Endogenously expressed UNG1; peptide generated by trypsin in blue (mUNG1-19-29) was identified in CH12F2 UNG2-KO cell extracts. All other data are from exogenously expressed mUNG1-1-38-GFP. mUNG1-1-38-GFP was immuneprecipitated (GFP-IP) from transfected NIH-3T3 cells followed by LysC digestion (cleaves after K) on the beads. Further, all possible peptides after eventual proteolytic cleavage in the N-terminal region were targeted using PRM-based targeted mass spectrometry (see materials and methods section). Data analysis using Skyline (UW, Seattle, WA) identified peptides (SLTPNPDSDSRQ ASPAK/LTPNPDSDSRQ ASPAK), shown by peak intensity and peak area of the MS2 fragments, corresponding to proteolytic cleavage of mUNG1 between R18/S19 and S19/L20. Figure S5. RPA2 and PCNA pull down experiments; UNG1 binds RPA and UNG2 binds RPA and PCNA. U2OS cells were transfected with various UNG-GFP constructs (h: human, m: mouse) as indicated and GFP-IP were performed from WCE (500 µg total protein) as described. Nuclease-treated extracts were used to pulldown PCNA. Western blot analysis were performed on IP and input. UNG-GFP variants (and GFP control) were detected by GFP Ab (ab 290) and IRDye 680RD goat anti-rabbit (red). RPA2 and PCNA were detected with primary antibodies RPA2 Ab [EPR2877Y] (ab76420) and PCNA Ab (ab18197), respectively, using IRDye 800CW Goat anti-rabbit as secondary Ab (green). β-actin (input loading control) was detected by monoclonal mouse anti-β-Actin (ab 8226) and IRDye 680RD goat anti-mouse (red). Proteins were visualized on a LI-COR Odyssey Imaging system. The mutations in the PCNA and RPA2 binding sites are indicated. C. Figure S6 . mUNG1 interacts physically with RPA in the nucleus. A. Ribbon structure of the C-terminal WH-domain of RPA2 bound to the UNG RPA binding motif. The figure was generated using PyMOL Molecular Graphic system and coordinates PDB ID 1DPU. The side chains representing mUNG1 N58 and R65 are visualized. B. RPA2 pull-down experiment (GFP-IP) were performed as described, using mUNG1-GFP (WT and mutants) as bait. WCE were generated from U2OS cells transfected with the constructs indicated. UNG1-GFP and RPA2 were detected as described in figure S4 C. Confocal microscopy images of live U2OS cells treated with hydroxyurea for 24 h. Cells were transfected with various mUNG1-GFP constructs as indicated. Colocalization of mUNG1 and RPA2 in the nucleus were analyzed using the LSM 510 META line profile software tool and regression analysis (R 2 ) of CFP and YFP intensity along the line (blue and yellow curves, respectively) were performed in Excel. Intensity profiles
